Skip to main content
Clinical Trials/DRKS00023023
DRKS00023023
Completed
Phase 4

Randomized-controlled trial investigating the effectiveness of a digital life-style intervention to improve quality of life in people with multiple sclerosis. - DiQoLiMS

GAIA AG0 sites421 target enrollmentSeptember 22, 2020

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
G35
Sponsor
GAIA AG
Enrollment
421
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 22, 2020
End Date
July 9, 2022
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
GAIA AG

Eligibility Criteria

Inclusion Criteria

  • Initial diagnosis of multiple sclerosis at least one year before study enrollment, specialist treatment in the last three months before study enrollment, sufficient cognitive and motor skills to use an online program, consent to participate in the study, sufficient understanding of the German language, access to the internet through own smartphone or computer

Exclusion Criteria

  • See inclusion criteria, psychotic diseases (e.g. schizophrenia), bipolar disorders, suicidal thoughts

Outcomes

Primary Outcomes

Not specified

Similar Trials